NDC 2019 on CNS tumors will review developments in understanding the molecular pathogenesis of pediatric brain tumors, and how more targeted therapies are improving life expectancy and quality of life.
- Describe molecular advances in tumor classification.
- Better understand the evolution of targeted therapies.
- More clearly formulate a treatment plan for patients.
- New diagnostic strategies.
- Incorporating modern targeted therapies.
- Encouraging accrual to novel clinical trials.